January 30, 2019
Real World Evidence of the Effectiveness of Paritaprevir/r – Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C – An Observational Study in Germany (LIFE-C)
Read More
January 30, 2019
Real World Evidence of the Effectiveness of Paritaprevir/r – Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C – An Observational Study in Germany (LIFE-C)
Read More
December 10, 2018
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
Read More
X